Prevalence of Atopic Dermatitis: A Systematic Review and Meta-Analysis
Dermatitis® · 01.11.2025 · 36 (6) · 575-582
DOI: 10.1089/derm.2024.0165 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Dermatitis®, online erschienen am 17.02.2026. Verfasst von Celina Borges Migliavaca und 10 weiteren Autor:innen. Beteiligte Einrichtung: From the HTA Unit, Inova Medical, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Atopic dermatitis (AD) negatively affects quality of life and places a substantial financial burden on health care systems due to treatment costs and increased demand for services.
Objective
To estimate the worldwide prevalence of AD, the proportion of severe cases worldwide and explore sources of heterogeneity.
Methods
We searched MEDLINE, Embase, and Global Index Medicus from January 2012 up until August 30, 2022. We included primary prevalence studies published from 2012 onward. Study selection was conducted by two reviewers independently. One reviewer performed data extraction and assessed risk of bias using the JBI Critical Appraisal Checklist for Prevalence Studies, with independent checking by a second reviewer. Random-effects meta-analyses were conducted to pool results; subgroup analyses were conducted to evaluate potential modifiers. Certainty of evidence was rated using the Grading of Recommendations Assessment, Development, and Evaluation approach. Main outcomes were point prevalence and proportion of severe cases.
Results
We identified 12,774 unique references and assessed 1029 full texts, ultimately resulting in the inclusion of 310 studies with 25.5 million individuals. Point prevalence was 11.1% (95% CI 9.4–13.1; 123 studies; 12,776,910 individuals; moderate certainty of evidence) in children and adolescents, and 6.3% (95% CI 5.0–7.8; 59 studies; 12,794,260 individuals; moderate certainty of evidence) in adults. Relatively similar results were observed for studies with low risk of bias. Proportion of severe cases varied from 1.9 to 7.2% in children and adolescents and 2.8% to 15.6% in adults.
Conclusions
These findings may underpin effective health care policies, research initiatives, and clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- From the HTA Unit, Inova Medical, Porto Alegre, Brazil.
- Post-Graduate Program of Epidemiology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
- Faculty of Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
- Santa Casa de São Paulo, São Paulo, Brazil.
- Pfizer Brazil, São Paulo, Brazil.
- Pfizer Inc., Collegeville, Pennsylvania, USA.
ORCID-Profile: Daniela V Pachito
Zitieren
APA
Migliavaca, C. B., Lazzarini, R., Stein, C., Escher, G. N., de Gaspari, C. N., Dos Santos, H. W. G., Myers, D. E., Lemeshow, A. R., Pinheiro, M. R. T., Falavigna, M., & Pachito, D. V. (2025). Prevalence of Atopic Dermatitis: A Systematic Review and Meta-Analysis. Dermatitis®, 36(6), 575-582. https://doi.org/10.1089/derm.2024.0165
Vancouver
Migliavaca CB, Lazzarini R, Stein C, Escher GN, de Gaspari CN, Dos Santos HWG, et al. Prevalence of Atopic Dermatitis: A Systematic Review and Meta-Analysis. Dermatitis®. 2025;36(6):575-582. doi:10.1089/derm.2024.0165
BibTeX
@article{Migliavaca2025,
author = {Migliavaca, Celina Borges and Lazzarini, Rosana and Stein, Cinara and Escher, Gabrielle Nunes and de Gaspari, Camilla Natal and Dos Santos, Harryson Wings Godoy and Myers, Daniela E and Lemeshow, Adina R and Pinheiro, Márcia Regina Teixeira and Falavigna, Maicon and Pachito, Daniela V},
title = {Prevalence of Atopic Dermatitis: A Systematic Review and Meta-Analysis},
journal = {Dermatitis®},
year = {2025},
volume = {36},
number = {6},
pages = {575--582},
doi = {10.1089/derm.2024.0165}
}
EUVIMED